OVID
Ovid Therapeutics Inc.
+0.04 (+1.49%)2.72USD1.2M成交股數531M市值–本益比(近四季)335.6股價營收比-88.3%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 733K-88% | 0.00-100% | 718K+315% | 132K-22% | 6.3M+4138% | 130K-8% | 173K+59% | 169K+125% | 148K | 142K | 109K | 75K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 10.0M | 11.2M | 6.6M | 5.9M | 6.5M | 6.7M | 7.9M | 12.6M | 10.4M | 10.6M | 5.3M | 6.0M |
| 銷售管理費用 | 6.5M | 6.7M | 6.4M | 6.8M | 4.9M | 6.0M | 5.5M | 8.1M | 7.2M | 7.7M | 6.8M | 8.2M |
| 營業利益 | −15.7M+209% | −17.8M+42% | −12.3M-7% | −12.5M-39% | −5.1M-71% | −12.6M-31% | −13.2M+10% | −20.5M+45% | −17.4M | −18.2M | −12.0M | −14.2M |
| 營業利益率 | -2,141.6% | – | -1,712.1% | -9,487.1% | -80.9% | -9,653.8% | -7,645.1% | -12,140.2% | -11,768.2% | -12,808.5% | -11,035.8% | -18,896.0% |
| 稅後淨利 | −15.0M+220% | −17.0M+66% | 9.7M-169% | −12.2M-243% | −4.7M-60% | −10.2M-33% | −14.0M+24% | 8.5M-169% | −11.7M | −15.3M | −11.3M | −12.4M |
| 淨利率 | -2,047.6% | – | 1,347.8% | -9,210.6% | -74.7% | -7,873.1% | -8,096.0% | 5,042.0% | -7,901.4% | -10,762.7% | -10,323.9% | -16,544.0% |
| 稀釋 EPS | – | – | – | – | – | – | -0.20+25% | 0.12-167% | -0.17 | -0.21 | -0.16 | -0.18 |
| 稀釋股數 | – | – | – | – | – | – | 71.0M | 71.2M | 70.7M | 70.6M | 70.6M | 70.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.3M | 94.1M | 13.2M | 20.6M | 28.4M | 21.1M | 15.0M | 29.7M | 30.8M | 27.0M | 57.4M | 71.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 232M | 226M | 151M | 63.8M | 77.4M | 81.7M | 103M | 118M | 132M | 144M | 125M | 136M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 22.1M | 27.4M | 20.3M | 19.2M | 21.6M | 22.4M | 26.4M | 29.2M | 53.3M | 56.2M | 23.7M | 25.5M |
| 股東權益 | 210M | 198M | 131M | 44.7M | 55.8M | 59.3M | 76.3M | 88.9M | 78.3M | 87.8M | 101M | 111M |
| 負債比 | 9.5% | 12.1% | 13.4% | 30.0% | 27.9% | 27.4% | 25.7% | 24.7% | 40.5% | 39.0% | 19.0% | 18.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −13.9M+35% | – | – | – | −10.3M | – | – | −16.7M | – | – | – |
| 資本支出 | – | – | – | – | – | 0.00 | – | – | 19K | – | – | – |
| 自由現金流 | – | – | – | – | – | −10.3M | – | – | −16.7M | – | – | – |
| 折舊攤銷 | – | 35K | – | – | – | 141K | – | – | 136K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -7,907.7% | – | – | -11,287.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 7.3M
| Reportable | 7.3M | 100.0% | +1181.3% |
|---|
產品／服務2025 年度 · 231M
| Royalty License And Termination Agreement | 231M | 100.0% | +3.2% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 7.3M | -96.8% | −17.4M | -239.9% | – | −38.3M |
| FY2025 | 224M | +39405.3% | – | –% | – | – |
| FY2024 | 566K | -99.7% | −26.4M | -4,664.3% | – | −56.0M |
| FY2024 | 223M | +0.1% | – | –% | – | – |
| FY2024 | 223M | +0.1% | – | –% | – | – |
| FY2024 | 223M | +56787.8% | – | –% | – | – |
| FY2023 | 392K | -99.8% | −52.3M | -13,341.8% | -0.74 | −45.8M |
| FY2023 | 223M | – | – | –% | – | – |